Circassia, an Oxford-based biopharmaceutical company, has raised over £200m in an Initial Public Offering (IPO) on the London Stock Exchange. Circassia is focused on the development and commercialisation of a range of immunotherapy products for the treatment of allergies using the company’s innovative technology, ToleroMune®, which was initially developed at Imperial College, London. Circassia has […]
Registration is now open for Venturefest Oxford which takes place at the Said Business School on 8 July. Venturefest brings together hundreds of innovators, investors and entrepreneurs. Click here for more information.
The national clinical director of mental health for England has praised the work of the Oxford Academic Health Science Network. Dr Geraldine Strathdee made her comments after taking part in a mental health meeting in Oxford on 13 March which heard four of the Oxford AHSN clinical networks set out their plans. She tweeted: “Really […]
Oxford AHSN and other partners are teaming up with Proteus Digital Health to assess the impact of digitial medicines on patients. Sir John Bell, Regius Professor of Medicine at the University of Oxford, said: “The technology platform Proteus offers will allow digital health to become a reality, giving patients a role in managing their disease […]
Our March newsletter contains items on: AHSNs strengthening links between researchers and clinicians Mobile phone app development Masters fellowships in Evidence Based Healthcare Key appointments Coming events Patients’ video feedback leading to better care Read it all here
Mike Denis has been appointed as Director of Information Strategy at Oxford Academic Health Science Network (AHSN). Mike has 26 years experience working in NHS health informatics. He arrives from the South London and Maudsley NHS Foundation Trust where he holds a similar post. Mike is also senior informatics lead for the South London AHSN […]
Dr Nick Scott-Ram MBE has been appointed as Director of Commercial Development at Oxford Academic Health Science Network. Nick has over 22 years experience in commercial and business development in the life sciences sector. Dr Paul Durrands, Chief Operating Officer at Oxford AHSN, said: “We are delighted to have appointed Nick to this key post. […]
Oxford project using videos of patients discussing their treatment aids ward care in Reading and London. Read more here.
One fifth of the semi-finalists in the OneStart biotech ideas competition, which attracted entries from across Europe, are from Oxford. Read about the Oxford initiatives – and all 35 shortlisted entries – here. Finalists will be announced in April.
Mobile app development, Masters programme opportunities, news from around our region – and more…all in our latest newsletter.